James Charnock is a senior analyst in Public Health England’s National Cancer Registration and Analysis Service and Macmillan Cancer Support partnership. He leads on projects focusing on those living with and beyond cancer. Prior to joining PHE James worked for IMS Health on providing intelligence on cancer treatments to leading European pharmaceutical companies. James graduated with a Master’s of Science in Biomedical Science and Synthetic Organic Chemistry from University College London.
Today at the PHE conference the National Cancer Registration and Analysis Service (NCRAS), in partnership with Macmillan Cancer Support, released new figures showing that there were 1.87 million people living with and beyond a cancer diagnosis in England at the …
